Angela M Davies Selected Research

Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)

7/2013	Southwestern oncology group phase II trial (S0526) of pemetrexed in bronchioloalveolar carcinoma subtypes of advanced adenocarcinoma.
10/2011	Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003).
8/2007	Incorporating bortezomib into the treatment of lung cancer.
6/2004	Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angela M Davies Research Topics

Disease

26	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2013 - 01/2003
21	Neoplasms (Cancer) 07/2022 - 01/2003
9	Lung Neoplasms (Lung Cancer) 02/2008 - 08/2003
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2007 - 02/2004
4	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 07/2013 - 06/2004
3	Disease Progression 10/2011 - 11/2006
2	Exanthema (Rash) 12/2011 - 08/2011
2	Weight Loss (Weight Reduction) 11/2006 - 03/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2022
1	Primary Myelofibrosis (Myelosclerosis) 07/2022
1	Alveolar Rhabdomyosarcoma 01/2019
1	Embryonal Rhabdomyosarcoma 01/2019
1	Residual Neoplasm 01/2019
1	Adenocarcinoma of Lung 07/2013
1	Adenocarcinoma 07/2013
1	Glioblastoma (Glioblastoma Multiforme) 07/2013
1	Infections 12/2011
1	Diarrhea 12/2011
1	Mucositis 12/2011
1	Febrile Neutropenia 12/2011
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2009
1	Neoplasm Metastasis (Metastasis) 01/2009
1	Cardiotoxicity 10/2007
1	Esophagitis 11/2006
1	Neutropenia 11/2006
1	Mesothelioma 09/2006
1	Malignant Mesothelioma 07/2006
1	Xeroderma Pigmentosum (Kaposi's Disease) 03/2004
1	Breast Neoplasms (Breast Cancer) 03/2004

Drug/Important Bio-Agent (IBA)

11	Bortezomib (Velcade)FDA Link 10/2011 - 08/2003
10	ErbB Receptors (EGF Receptor)IBA 12/2011 - 03/2004
6	Tyrosine Kinase InhibitorsIBA 12/2011 - 05/2006
5	Pemetrexed (MTA)FDA Link 12/2013 - 07/2006
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2011 - 08/2007
5	Docetaxel (Taxotere)FDA Link 12/2011 - 04/2003
5	Proteasome InhibitorsIBA 01/2009 - 08/2003
3	Pharmaceutical PreparationsIBA 07/2013 - 10/2007
3	Gemcitabine FDA Link 01/2009 - 01/2008
3	Proteins (Proteins, Gene)FDA Link 08/2007 - 01/2003
2	entinostat (MS 275)IBA 01/2019 - 11/2018
2	DNA (Deoxyribonucleic Acid)IBA 12/2009 - 03/2004
2	Carboplatin (JM8)FDA LinkGeneric 01/2009 - 01/2008
2	Cisplatin (Platino)FDA LinkGeneric 11/2006 - 07/2006
2	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2005 - 02/2004
2	TubulinIBA 03/2004 - 04/2003
2	taxaneIBA 03/2004 - 04/2003
2	NF-kappa B (NF-kB)IBA 02/2004 - 08/2003
2	CyclinsIBA 02/2004 - 08/2003
1	mivebresibIBA 07/2022
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Histone Deacetylase InhibitorsIBA 01/2019
1	Drug CombinationsIBA 12/2013
1	130-nm albumin-bound paclitaxelIBA 12/2013
1	Antimitotic AgentsIBA 07/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2013
1	Folic Acid AntagonistsIBA 07/2013
1	Cetuximab (Erbitux)FDA Link 08/2011
1	Anaplastic Lymphoma KinaseIBA 04/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 02/2008
1	VaccinesIBA 02/2008
1	Immunomodulating AgentsIBA 02/2008
1	Platinum Compounds (Compounds, Platinum)IBA 01/2008
1	Biomarkers (Surrogate Marker)IBA 01/2008
1	Glucose (Dextrose)FDA LinkGeneric 10/2007
1	pertuzumabIBA 10/2007
1	Cytotoxins (Cytolysins)IBA 08/2007
1	Vinorelbine (Navelbine)FDA LinkGeneric 08/2007
1	Biological ProductsIBA 02/2007
1	AlbuminsIBA 11/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2006
1	Aurora KinasesIBA 09/2006
1	Antineoplastic Agents (Antineoplastics)IBA 09/2006
1	Aurora Kinase AIBA 09/2006
1	Cytostatic AgentsIBA 05/2006
1	UbiquitinIBA 10/2005
1	ATP dependent 26S protease (26S proteasome)IBA 08/2005
1	Apoptosis Regulatory ProteinsIBA 08/2005
1	AntimetabolitesIBA 03/2004
1	Trastuzumab (Herceptin)FDA Link 03/2004
1	Irinotecan (Camptosar)FDA LinkGeneric 03/2004
1	Antisense OligonucleotidesIBA 01/2003

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2019 - 03/2004
12	Therapeutics 07/2022 - 08/2003
1	Immunotherapy 02/2008
1	Chemoradiotherapy 11/2006